ZC3H13 and hepatocellular carcinoma: The miR-362-3p/miR-425-5p-ZC3H13 axis leads to downregulation of ZC3H13 and thus a reduction in m6A modifications, which correlates with poor prognosis and poor outcome in HCC patients (55).